International Study for Treatment of High Risk Childhood Relapsed ALL 2010

NCT03590171 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia (ALL)

Interventions

DRUG: Bortezomib

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]